LEE011
Drug timelines are a Plus or Pro feature.
8 regulatory and trial events tracked for LEE011, covering 2016-09-13 to 2026-04-07. Get the full timeline:
Most recent: Clinical Trial Update: LEE011 Plus Everolimus in Patients With Metastatic Pancreatic Adenocarcinoma Refractory to Chemotherapy [Phase 1, Phase 2]